GOING CONCERN

6 Months Ended

Aug. 31, 2025

GOING CONCERN

GOING CONCERN

NOTE C. GOING CONCERN

The accompanying financial statements have been prepared assuming that the Company will continue as a going concern. The Company has not generated significant revenue since its inception, has incurred recurring operating losses, has a working capital deficit and an accumulated deficit, and has experienced negative operating cash flows. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company’s ability to continue as a going concern is dependent upon the continued financial support of Dr. Burzynski through his medical practice, as provided under a research funding agreement. The Company is economically dependent on this arrangement. In the event that Dr. Burzynski is unable or unwilling to continue providing such funding, the Company would be required to obtain alternative financing. There can be no assurance that such financing will be available on acceptable terms, or at all. If the Company is unable to obtain such funding, it would likely be required to cease operations.

Management is evaluating strategic options to secure additional sources of capital through equity or debt financing, or other arrangements. However, there can be no assurance that these efforts will be successful. Even with Dr. Burzynski’s continued contributions, additional funding may be required until the Company achieves positive cash flows from operations, which may never occur.

Accordingly, the financial statements do not include any adjustments that might result from the outcome of this uncertainty.